Tango Therapeutics

About:

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Website: https://www.tangotx.com

Twitter/X: tango_tx

Top Investors: Fidelity, RA Capital Management, Bain Capital Life Sciences, Samsara BioCapital, Farallon Capital Management

Description:

Tango Therapeutics operator of a biotechnology company created to discover novel drug targets and deliver the next generation of targeted therapies to people with cancer. The company's research leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at driver genes in cancer that are focused on three core areas, including counteracting tumor suppressor gene loss, reversing the ability of cancer cells to evade the immune system and identifying novel combinations, enabling patients to get therapies that are more effective than single-agent therapy.

Total Funding Amount:

$351M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-01-01

Founders:

Alan Ashworth, José Baselga, Timothy K. Lu

Number of Employees:

101-250

Last Funding Date:

2021-08-11

IPO Status:

Public

© 2025 bioDAO.ai